Pandemic Incident Management for Vaccine Safety Challenges: Victoria's Alert Advisory Group Experience

被引:1
|
作者
Clothier, Hazel J. [1 ,2 ,3 ,4 ]
Wolthuizen, Michelle [3 ]
Laemmle-Ruff, Ingrid [2 ]
Lewis, Georgina [2 ]
Radkowski, Catherine [5 ]
Buttery, Jim [1 ,2 ,3 ,4 ,6 ]
Crawford, Nigel [2 ,3 ,4 ,6 ]
机构
[1] Melbourne Childrens Campus, Ctr Hlth Analyt, Epi Informat, Parkville, Vic, Australia
[2] Murdoch Childrens Res Inst, Surveillance Adverse Events Following Vaccinat Com, Melbourne, Vic, Australia
[3] Dept Hlth Victoria, COVID 19 Response, Melbourne, Australia
[4] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia
[5] Dept Hlth Victoria, Immunisat Unit, Melbourne, Australia
[6] Royal Childrens Hosp, Dept Gen Med, Infect Dis, Melbourne, Vic, Australia
关键词
biosecurity; vaccine safety; immunization; surveillance; incident control; pandemic; EVENTS FOLLOWING IMMUNIZATION; SURVEILLANCE; HEALTH;
D O I
10.1017/dmp.2024.100
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Safe vaccines are critical for biosecurity protection, yet adverse events-rightly or wrongly attributed to immunization-potentially cause rapid loss of confidence, reduced vaccine uptake, and resurgence of preventable disease. Effective vaccine safety incident management is essential to provide assessment and lead appropriate actions to ensure vaccination programs are safe and mitigate unwarranted crisis escalation that could damage vaccine programs and the effective control of vaccine preventable disease outbreaks or pandemics. Incident management systems (IMS) are used globally to direct emergency management response, particularly for natural disasters of fire, flood, and storm. Public health is equally an emergency response and can therefore benefit from these command control constructs. While examples of IMS for outbreak response and mass immunization logistics exist, there is little to no information on their use in vaccine safety. We describe Australia's vaccine safety Alert Advisory Group establishment in Victoria during the COVID-19 pandemic and onward embedding into routine practice, anticipant of new vaccines, and the next biosecurity threat.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Contributions and challenges for worldwide vaccine safety: The Global Advisory Committee on Vaccine Safety at 15 years
    Asturias, Edwin J.
    Wharton, Melinda
    Pless, Robert
    MacDonald, Noni E.
    Chen, Robert T.
    Andrews, Nicholas
    Salisbury, David
    Dodoo, Alexander N.
    Hartigan-Go, Kenneth
    Zuber, Patrick L. F.
    VACCINE, 2016, 34 (29) : 3342 - 3349
  • [2] Challenges and successes for the grantees and the Technical Advisory Group of WHO's influenza vaccine technology transfer initiative
    Grohmann, Gary
    Francis, Donald P.
    Sokhey, Jaspal
    Robertson, James
    VACCINE, 2016, 34 (45) : 5420 - 5424
  • [4] Safety of meningococcal group B vaccine: experience from the UK
    Seabroke, S.
    Bryan, P.
    DRUG SAFETY, 2017, 40 (10) : 1003 - 1003
  • [5] Community advisory boards' successes and challenges in AIDS vaccine clinical trials: a Southern Africa experience
    Mokhele, T.
    RETROVIROLOGY, 2009, 6
  • [6] SIOP EPENDYMOMA II: CENTRAL EPENDYMOMA MANAGEMENT ADVISORY GROUP - THE UK EXPERIENCE
    Macarthur, Donald C.
    Mallucci, Conor
    Kamaly-Asl, Ian
    Goodden, John
    Storer, Lisa C. D.
    Chapman, Rebecca J.
    Kilday, J-P
    English, Martin
    Jaspan, Tim
    Chattopadhyay, Arpita
    Dineen, Rob A.
    Avula, Shivaram
    Stivaros, Stavros
    Grundy, Richard
    NEURO-ONCOLOGY, 2020, 22 : 312 - 312
  • [7] COVID-19 Vaccine Safety Technical (VaST) Work Group: Enhancing vaccine safety monitoring during the pandemic*,**
    Markowitz, Lauri E.
    Hopkins Jr, Robert H.
    Broder, Karen R.
    Lee, Grace M.
    Edwards, Kathryn M.
    Daley, Matthew F.
    Jackson, Lisa A.
    Nelson, Jennifer C.
    Riley, Laura E.
    McNally, Veronica V.
    Schechter, Robert
    Whitley-Williams, Patricia N.
    Cunningham, Francesca
    Clark, Matthew
    Ryan, Margaret
    Farizo, Karen M.
    Wong, Hui-Lee
    Kelman, Jeffery
    Beresnev, Tatiana
    Marshall, Valerie
    Shay, David K.
    Gee, Julianne
    Woo, Jared
    McNeil, Michael M.
    Su, John R.
    Shimabukuro, Tom T.
    Wharton, Melinda
    Talbot, H. Keipp
    VACCINE, 2024, 42
  • [8] Assessing vaccine safety during a pandemic: Recent experience and lessons learned for the future
    Black, Steven B.
    Chandler, Rebecca E.
    Edwards, Kathryn M.
    Sturkenboom, Miriam C. J. M.
    VACCINE, 2023, 41 (25) : 3790 - 3795
  • [9] Safety Monitoring in Group A Meningococcal Conjugate Vaccine Trials: Description, Challenges, and Lessons
    Enwere, Godwin C.
    Paranjape, Gandhali
    Kulkarni, Prasad S.
    Ginde, Manisha
    Hartmann, Katharina
    Viviani, Simonetta
    Chaumont, Julie
    Martellet, Lionel
    Makadi, Marie-Francoise
    Ivinson, Karen
    Marchetti, Elisa
    Herve, Jacques
    Kertson, Kim
    LaForce, F. Marc
    Preziosi, Marie-Pierre
    CLINICAL INFECTIOUS DISEASES, 2015, 61 : S501 - S506
  • [10] Developing a seasonal influenza vaccine recommendation in Kenya: Process and challenges faced by the National Immunization Technical Advisory Group (NITAG)
    Dawa, Jeanette
    Chaves, Sandra S.
    Nguz, Antoinette Ba
    Kalani, Rosalia
    Anyango, Edwina
    Mutie, Dominic
    Muthoka, Phillip
    Tabu, Collins
    Maritim, Marybeth
    Amukoye, Evans
    Were, Fred
    Gatheru, Zipporah
    Wangai, Kiama
    Githanga, David
    Ongore, Dismas
    Gander, Christopher
    Osano, Bonface
    Tuet, Julius
    Maree, Ephantus
    Thuo, Samson
    VACCINE, 2019, 37 (03) : 464 - 472